文献速递复苏、休克与脓毒症消化、代谢与肾脏急症

急诊科对报告青霉素过敏患者使用β-内酰胺类抗生素

Administration of β-lactam antibiotics to patients with reported penicillin allergy in the emergency department.
PubMed 文献 · Am J Emerg Med · 2023-03-21
一句话结论回顾性研究显示,819例有青霉素过敏史患者在急诊使用β-内酰胺类抗生素后无IgE介导反应发生,支持对此类患者使用β-内酰胺类。

本研究为单中心回顾性病历审查,纳入2015年1月至2019年12月在学术医疗中心急诊科就诊、年龄≥18岁、有青霉素过敏报告但仍接受β-内酰胺类抗生素的819例患者(66%女性)。既往报告过敏反应类型包括荨麻疹(22.5%)、皮疹(15.4%)、肿胀(6.2%)、过敏性休克(3.5%)、其他(12.1%)及电子病历未记录(40.3%)。主要结局为β-内酰胺类给药后IgE介导反应的发生频率,结果无患者发生IgE介导反应;次要结局为出院或入院时β-内酰胺类的继续使用频率,既往过敏报告对继续使用无影响(OR:1,95% CI:0.7-1.44),有IgE介导青霉素过敏史者77%在离开急诊后继续使用β-内酰胺类。作者认为数据支持对记录有青霉素过敏的患者使用β-内酰胺类。

要点

  • 819例有青霉素过敏报告的患者在急诊接受β-内酰胺类抗生素,无1例发生IgE介导反应。
  • 既往青霉素过敏报告不影响β-内酰胺类在入院或出院时的继续使用(OR:1,95% CI:0.7-1.44)。
  • 有IgE介导青霉素过敏史的患者中77%在离开急诊后继续使用β-内酰胺类。
  • 既往报告过敏类型以荨麻疹(22.5%)和皮疹(15.4%)最常见,40.3%电子病历未记录反应类型。
  • 作者认为本研究数据支持对记录有青霉素过敏的患者使用β-内酰胺类抗生素。

适用人群与场景

  • 年龄≥18岁、在学术医疗中心急诊科就诊、有青霉素过敏报告但仍接受β-内酰胺类抗生素的患者。
  • 排除未接受β-内酰胺类或给药前未报告青霉素过敏的患者。

研究设计与关键结果

  • 研究类型:单中心回顾性病历审查;纳入2015年1月至2019年12月急诊科819例患者(66%女性)。
  • 既往报告青霉素反应:荨麻疹22.5%、皮疹15.4%、肿胀6.2%、过敏性休克3.5%、其他12.1%、电子病历未记录40.3%。
  • 主要结局:急诊给予β-内酰胺类后无患者发生IgE介导反应。
  • 次要结局:既往过敏报告对入院或出院时继续使用β-内酰胺类无影响(OR:1,95% CI:0.7-1.44)。
  • 有IgE介导青霉素过敏史的患者中77%在离开急诊(入院或出院)后继续使用β-内酰胺类。

证据类型、等级与局限

  • 证据类型:单中心回顾性病历审查。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为本研究数据支持对记录有青霉素过敏的患者使用β-内酰胺类抗生素。
  • 本研究显示急诊对报告青霉素过敏患者使用β-内酰胺类后无IgE介导反应,且未增加不良反应。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: β-lactam antibiotics are amongst the most commonly prescribed medications in the Emergency Department (ED) due to their role in empiric sepsis therapy; however, inferior therapeutic options are often utilized due to a reported allergy; penicillin (PCN) being most frequent. In the United States, 10% of the population endorses an allergic reaction to PCN while <1% experience IgE-mediated reactions. This study aimed to evaluate the frequency and outcome of patients in the ED whose PCN allergies were challenged with β-lactam antibiotics.

METHODS: We conducted a retrospective chart review of patients in the ED at an academic medical center aged ≥18, and who received a β-lactam despite a reported PCN allergy between January 2015 and December 2019. Patients who did not receive a β-lactam or did not report a PCN allergy prior to administration were excluded. The primary outcome was the frequency of IgE-mediated reactions in response to β-lactam administration. A secondary outcome assessed the frequency of continuation of β-lactams upon admission from the ED.

RESULTS: 819 patients were included (66% female) with prior reported PCN reactions: hives (22.5%), rash (15.4%), swelling (6.2%), anaphylaxis (3.5%), other (12.1%), or undocumented on medical electronic record (40.3%). No patients experienced an IgE-mediated reaction to the β-lactam administered in the ED. Previously reported allergies had no effect on the continuation of β-lactams when admitted or discharged (OR: 1, 95% CI: 0.7-1.44). Patients who had a history of an IgE-mediated penicillin allergy were frequently continued (77%) on a β-lactam after leaving the ED via admission or discharge.

CONCLUSION: β-lactam administration in patients with previously reported PCN allergies did not result in any IgE-mediated reactions nor in an increase in adverse reactions. Our data contributes to the body of evidence that supports the administration of β-lactams to patients with documented PCN allergies.

来源:Am J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Holmes MD, Vo N, Rafeq R, et al. Administration of β-lactam antibiotics to patients with reported penicillin allergy in the emergency department. Am J Emerg Med. 2023. PMID: 36972634. doi:10.1016/j.ajem.2023.03.013

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。